Back
Cocrystal Pharma Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
50
COCP
Cocrystal Pharma
Last Price:
$1.51
Seasonality Move:
13.15%
7 Day Trial
ALL ACCESS PASS
$
7

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
The current trend is relatively stagnant and COCP is experiencing selling pressure, which indicates risk of future bearish movement.
Cocrystal Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.53 | Sell |
20-day SMA: | 1.5 | Sell |
50-day SMA: | 1.5 | Sell |
200-day SMA: | 1.83 | Sell |
8-day EMA: | 1.52 | Sell |
20-day EMA: | 1.51 | Sell |
50-day EMA: | 1.55 | Sell |
200-day EMA: | 1.79 | Sell |
Cocrystal Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 46.75 | Sell |
Chaikin Money Flow: | -40390 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.32 - 1.6) | Sell |
Bollinger Bands (100): | (1.41 - 2.17) | Sell |
Cocrystal Pharma Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cocrystal Pharma Stock
Is Cocrystal Pharma Stock a Buy?
-
Cocrystal Pharma share price is 1.46 while COCP 8-day simple moving average is 1.53, which is a Sell signal.
-
The stock price of COCP is 1.46 while Cocrystal Pharma 20-day SMA is 1.50, which makes it a Sell.
-
Cocrystal Pharma 50-day simple moving average is 1.50 while COCP share price is 1.46, making it a Sell technically.
-
COCP stock price is 1.46 and Cocrystal Pharma 200-day simple moving average is 1.83, creating a Sell signal.
COCP Technical Analysis vs Fundamental Analysis
Sell
50
Cocrystal Pharma (COCP)
is a Sell
Is Cocrystal Pharma a Buy or a Sell?
-
Cocrystal Pharma stock is rated a SellThe current Cocrystal Pharma [COCP] share price is $1.46. The Score for COCP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Cocrystal Pharma Stock Info
Market Cap:
14.9M
Price in USD:
1.46
Share Volume:
40.4K
Cocrystal Pharma 52-Week Range
52-Week High:
3.26
52-Week Low:
1.12
Sell
50
Cocrystal Pharma (COCP)
is a Sell
Cocrystal Pharma Share Price Forecast
-
What is the Cocrystal Pharma stock price today?The Cocrystal Pharma stock price is 1.46 USD today.
-
Will COCP stock go up or go down?Cocrystal Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Cocrystal Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cocrystal Pharma is overvalued.
Is Cocrystal Pharma Stock a Buy?
-
Cocrystal Pharma share price is 1.46 while COCP 8-day exponential moving average is 1.52, which is a Sell signal.
-
The stock price of COCP is 1.46 while Cocrystal Pharma 20-day EMA is 1.51, which makes it a Sell.
-
Cocrystal Pharma 50-day exponential moving average is 1.55 while COCP share price is 1.46, making it a Sell technically.
-
COCP stock price is 1.46 and Cocrystal Pharma 200-day simple moving average is 1.79, creating a Sell signal.
Fundamental Analysis of Cocrystal Pharma
Is Cocrystal Pharma a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
Technical Analysis of Cocrystal Pharma
Should I short Cocrystal Pharma stock?
-
COCP Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Cocrystal Pharma is a Buy
-
Cocrystal Pharma Relative Strength Index (RSI) is 46.75, which suggest Cocrystal Pharma is oversold
-
The Bollinger Bands (25) for Cocrystal Pharma is (1.32 - 1.6), which suggest Cocrystal Pharma is a Sell
-
The Bollinger Bands (100) for Cocrystal Pharma is (1.41 - 2.17), which suggest Cocrystal Pharma is a Sell
* Cocrystal Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.